Patents by Inventor MAX ECHTERLING

MAX ECHTERLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PCSK9 ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240189454
    Abstract: The present disclosure provides improved genome editing compositions and methods for editing a PCSK9 gene. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of hypercholesterolemia or a condition associated therewith.
    Type: Application
    Filed: August 30, 2023
    Publication date: June 13, 2024
    Applicant: 2Seventy bio, Inc.
    Inventors: Jordan JARJOUR, Kyle HAVENS, Michael CERTO, Max ECHTERLING
  • PCSK9 ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20200376140
    Abstract: The present disclosure provides improved genome editing compositions and methods for editing a PCSK9 gene. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of hypercholesterolemia or a condition associated therewith.
    Type: Application
    Filed: October 4, 2018
    Publication date: December 3, 2020
    Applicant: bluebird bio, Inc.
    Inventors: JORDAN JARJOUR, KYLE HAVENS, MICHAEL CERTO, MAX ECHTERLING